Lv1
40 积分 2024-06-07 加入
Trispecific anti-CLDN-18.2/CD3/CD28 antibodies for gastric cancer treatment
13小时前
已完结
Enhancing the activation of T cells through anti‐CD3/CD28 magnetic beads by adjusting the antibody ratio
29天前
已完结
Engineering potent chimeric antigen receptor T cells by programming signaling during T-cell activation
29天前
已完结
Preclinical Activity of the DLL3-Targeted T-cell Engager MK-6070 in Neuroendocrine Prostate Cancer
1个月前
已完结
Preclinical Activity of the DLL3-Targeted T-cell Engager MK-6070 in Neuroendocrine Prostate Cancer
1个月前
已完结
A comparison of different intensified upstream processes highlighting the advantage of WuXi Biologics' Ultra‐high Productivity platform ( WuXiUP TM ) in improved product quality and purification yield
2个月前
已完结
Recent advances in radionuclide drug conjugates (RDCs) for cancer theranostics: From targeted design to clinical translation
3个月前
已完结
Study on the hole and knob related impurities in the purification of bispecific antibodies
3个月前
已完结
Input Determines Output: Building a Protein Expression Platform
4个月前
已完结
A case study of a bispecific antibody manufacturability assessment and optimization during discovery stage and its implications
4个月前
已完结
皖公网安备34019202002308
